Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Lung ultrasound score for telling apart several lung diseases

Tests a lung ultrasound score of lung movement in adults with lung conditions.

Plain-language title generated from the registry record
Registry title: Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

Key facts

Where
Asyut, EgyptSee the site

Where in Egypt

  • Assiut University- Faculty of MedicineAsyut, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Assiut University
Trial code
NCT06983366
Record updated
22 September 2026
Original description
This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.Read full original descriptionShow less

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases: A Prospective Case-Control Study

This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.

Inclusion: Age 18 years and older; Diagnosed with one of the specified pulmonary diseases, or a healthy control; Able to provide written informed consent.

Exclusion: Inability to tolerate or undergo a lung ultrasound; Extensive chest wall pathology precluding assessment; Unscorable >2 zones per protocol; Withdrawal of consent; Mechanically-ventilated patients.

ClinicalTrials.gov NCT06983366